# Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

> **NCT06297772** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 220 (estimated)

## Conditions studied

- AML, Adult

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Fludarabine Injection
- **DRUG:** Busulfan Injection

## Key facts

- **NCT ID:** NCT06297772
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06297772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06297772, "Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06297772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*